Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multi-center Observational Trial to Assess Persistence on Active Surveillance When Using the OncotypeDX® Prostate Cancer Assay

NCT03502213 is registered in ClinicalTrials.gov with Genomic Health®, Inc. as lead sponsor.

NCT NCT03502213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03502213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multi-center Observational Trial to Assess Persistence on Active Surveillance When Using the OncotypeDX® Prostate Cancer Assay
Lead sponsor
Genomic Health®, Inc.
Phase
Observational
Overall status
Completed
Start date
July 1, 2014
Completion date
June 30, 2018
Enrollment
489 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer